Literature DB >> 21862609

Repressor of estrogen receptor activity (REA) is essential for mammary gland morphogenesis and functional activities: studies in conditional knockout mice.

Sunghee Park1, Yuechao Zhao, Sangyeon Yoon, Jianming Xu, Lan Liao, John Lydon, Franco DeMayo, Bert W O'Malley, Benita S Katzenellenbogen.   

Abstract

Estrogen receptor (ER) is a key regulator of mammary gland development and is also implicated in breast tumorigenesis. Because ER-mediated activities depend critically on coregulator partner proteins, we have investigated the consequences of reduction or loss of function of the coregulator repressor of ER activity (REA) by conditionally deleting one allele or both alleles of the REA gene at different stages of mammary gland development. Notably, we find that heterozygosity and nullizygosity for REA result in very different mammary phenotypes and that REA has essential roles in the distinct morphogenesis and functions of the mammary gland at different stages of development, pregnancy, and lactation. During puberty, mice homozygous null for REA in the mammary gland (REAf/f PRcre/+) showed severely impaired mammary ductal elongation and morphogenesis, whereas mice heterozygous for REA (REAf/+ PRcre/+) displayed accelerated mammary ductal elongation, increased numbers of terminal end buds, and up-regulation of amphiregulin, the major paracrine mediator of estrogen-induced ductal morphogenesis. During pregnancy and lactation, mice with homozygous REA gene deletion in mammary epithelium (REAf/f whey acidic protein-Cre) showed a loss of lobuloalveolar structures and increased apoptosis of mammary alveolar epithelium, leading to impaired milk production and significant reduction in growth of their offspring, whereas body weights of the offspring nursed by females heterozygous for REA were slightly greater than those of control mice. Our findings reveal that REA is essential for mammary gland development and has a gene dosage-dependent role in the regulation of stage-specific physiological functions of the mammary gland.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862609      PMCID: PMC3199013          DOI: 10.1210/en.2011-1100

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  59 in total

Review 1.  Signaling pathways in mammary gland development.

Authors:  L Hennighausen; G W Robinson
Journal:  Dev Cell       Date:  2001-10       Impact factor: 12.270

Review 2.  Hormonal regulation of mammary differentiation and milk secretion.

Authors:  Margaret C Neville; Thomas B McFadden; Isabel Forsyth
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

3.  Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation.

Authors:  Yongzhi Cui; Greg Riedlinger; Keiko Miyoshi; Wei Tang; Cuiling Li; Chu-Xia Deng; Gertraud W Robinson; Lothar Hennighausen
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 4.  Steroid receptors and cell cycle in normal mammary epithelium.

Authors:  Elizabeth Anderson; Robert B Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

5.  A novel LacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development.

Authors:  Preeti M Ismail; Jie Li; Francesco J DeMayo; Bert W O'Malley; John P Lydon
Journal:  Mol Endocrinol       Date:  2002-11

6.  Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence.

Authors:  P J Coates; R Nenutil; A McGregor; S M Picksley; D H Crouch; P A Hall; E G Wright
Journal:  Exp Cell Res       Date:  2001-05-01       Impact factor: 3.905

7.  High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene.

Authors:  Maria I Torres-Arzayus; Jaime Font de Mora; Jing Yuan; Francisca Vazquez; Roderick Bronson; Montserrat Rue; William R Sellers; Myles Brown
Journal:  Cancer Cell       Date:  2004-09       Impact factor: 31.743

8.  Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases.

Authors:  Vladislav Kurtev; Raphael Margueron; Karin Kroboth; Egon Ogris; Vincent Cavailles; Christian Seiser
Journal:  J Biol Chem       Date:  2004-03-31       Impact factor: 5.157

9.  The mitochondrial prohibitin complex is essential for embryonic viability and germline function in Caenorhabditis elegans.

Authors:  Marta Artal-Sanz; William Y Tsang; Esther M Willems; Les A Grivell; Bernard D Lemire; Hans van der Spek; Leo G J Nijtmans; Marta Artal Sanz
Journal:  J Biol Chem       Date:  2003-06-06       Impact factor: 5.157

Review 10.  The roles of sex steroid receptor coregulators in cancer.

Authors:  Xiuhua Gao; Brian W Loggie; Zafar Nawaz
Journal:  Mol Cancer       Date:  2002-11-14       Impact factor: 27.401

View more
  14 in total

1.  Uterine development and fertility are dependent on gene dosage of the nuclear receptor coregulator REA.

Authors:  Sunghee Park; Sangyeon Yoon; Yuechao Zhao; Seong-Eun Park; Lan Liao; Jianming Xu; John P Lydon; Francesco J DeMayo; Bert W O'Malley; Milan K Bagchi; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2012-05-14       Impact factor: 4.736

Review 2.  Prohibitin - At the crossroads of obesity-linked diabetes and cancer.

Authors:  Suresh Mishra; Bl Grégoire Nyomba
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-11

3.  Loss of Amphiregulin drives inflammation and endothelial apoptosis in pulmonary hypertension.

Authors:  Jonathan Florentin; Jingsi Zhao; Yi-Yin Tai; Wei Sun; Lee L Ohayon; Scott P O'Neil; Anagha Arunkumar; Xinyi Zhang; Jianhui Zhu; Yassmin Al Aaraj; Annie Watson; John Sembrat; Mauricio Rojas; Stephen Y Chan; Partha Dutta
Journal:  Life Sci Alliance       Date:  2022-06-22

4.  Estradiol inhibits Th17 cell differentiation through inhibition of RORγT transcription by recruiting the ERα/REA complex to estrogen response elements of the RORγT promoter.

Authors:  Rong-Yi Chen; Yi-Ming Fan; Qiuyang Zhang; Sen Liu; Qingli Li; Guo-Lin Ke; Chen Li; Zongbing You
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

5.  Multiple Beneficial Roles of Repressor of Estrogen Receptor Activity (REA) in Suppressing the Progression of Endometriosis.

Authors:  Yuechao Zhao; Yiru Chen; Ye Kuang; Milan K Bagchi; Robert N Taylor; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2015-12-14       Impact factor: 4.736

6.  The coregulator, repressor of estrogen receptor activity (REA), is a crucial regulator of the timing and magnitude of uterine decidualization.

Authors:  Yuechao Zhao; Sunghee Park; Milan K Bagchi; Robert N Taylor; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2013-02-07       Impact factor: 4.736

Review 7.  Derailed estrogen signaling and breast cancer: an authentic couple.

Authors:  Bramanandam Manavathi; Oindrilla Dey; Vijay Narsihma Reddy Gajulapalli; Raghavendra Singh Bhatia; Suresh Bugide; Rakesh Kumar
Journal:  Endocr Rev       Date:  2012-09-04       Impact factor: 19.871

Review 8.  Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development.

Authors:  Bramanandam Manavathi; Venkata S K Samanthapudi; Vijay Narasimha Reddy Gajulapalli
Journal:  Front Cell Dev Biol       Date:  2014-08-12

9.  Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy.

Authors:  Zhuan Zhou; Joe X Qiao; Amit Shetty; George Wu; Yi Huang; Nancy E Davidson; Yong Wan
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.207

10.  Spatial mapping of juxtacrine axo-glial interactions identifies novel molecules in peripheral myelination.

Authors:  Y Poitelon; S Bogni; V Matafora; G Della-Flora Nunes; E Hurley; M Ghidinelli; B S Katzenellenbogen; C Taveggia; N Silvestri; A Bachi; A Sannino; L Wrabetz; M L Feltri
Journal:  Nat Commun       Date:  2015-09-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.